No price history available.
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 12 | 18 | 22 | 25 | 15 | 29 | N/A | N/A |
| Operating profit | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | £m | 14 | 20 | 20 | 12 | 2 | 11 | N/A | N/A |
| EPS reported | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Duke Capital Limited operates as a private equity firm primarily engaged in Management Buyouts (MBOs), buy-and-build strategies, mid-market investments, minority buyouts, restructuring endeavors, and royalty financing for small to medium-sized enterprises (SMEs). The firm explicitly avoids investing in early-stage ventures, businesses with inherently tight profit margins, and does not provide venture capital funding. While its investment scope spans all sectors, Duke Capital exhibits a distinct preference for companies in manufacturing, services, healthcare, and IT services. Equity investments typically range from £5 million (approximately $6.36 million) to £30 million (around $38.18 million), targeting businesses with an EBITDA between £2 million ($2.54 million) and £10 million ($12.72 million). Additionally, the firm offers debt financing, with loan sizes generally falling between £10 million (approximately $12.72 million) and £30 million (roughly $38.18 million). Key investment criteria include a strong emphasis on intellectual property assets and financially stable, cash-generating businesses. It also favors companies with minimal or no existing debt, and partnerships with owners who wish to retain significant control or with management teams pursuing buyout opportunities. A core strategy involves providing capital in exchange for a modest share of future revenues, via royalty agreements. The firm shows a preference for businesses operating under government or regulatory licenses and generally seeks board representation within its portfolio companies, where it typically acquires minority stakes. Established in 2015, Duke Capital Limited is headquartered in Guernsey, with additional operational bases in both Guernsey and London, United Kingdom.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Duke Capital Limited (DUKE.L)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Duke Capital Limited operates as a private equity firm primarily engaged in Management Buyouts (MBOs), buy-and-build strategies, mid-market investments, minority buyouts, restructuring endeavors, and royalty financing for small to medium-sized enterprises (SMEs). The firm explicitly avoids investing in early-stage ventures, businesses with inherently tight profit margins, and does not provide venture capital funding. While its investment scope spans all sectors, Duke Capital exhibits a distinct preference for companies in manufacturing, services, healthcare, and IT services. Equity investments typically range from £5 million (approximately $6.36 million) to £30 million (around $38.18 million), targeting businesses with an EBITDA between £2 million ($2.54 million) and £10 million ($12.72 million). Additionally, the firm offers debt financing, with loan sizes generally falling between £10 million (approximately $12.72 million) and £30 million (roughly $38.18 million). Key investment criteria include a strong emphasis on intellectual property assets and financially stable, cash-generating businesses. It also favors companies with minimal or no existing debt, and partnerships with owners who wish to retain significant control or with management teams pursuing buyout opportunities. A core strategy involves providing capital in exchange for a modest share of future revenues, via royalty agreements. The firm shows a preference for businesses operating under government or regulatory licenses and generally seeks board representation within its portfolio companies, where it typically acquires minority stakes. Established in 2015, Duke Capital Limited is headquartered in Guernsey, with additional operational bases in both Guernsey and London, United Kingdom.
